ArticleHuman vaccines & immunotherapeutics2025

Adverse reactions following first three doses of the BNT162b2 mRNA COVID-19 vaccine: A prospective cohort study on relationships with individual characteristics and previous experience of adverse reactions.

Ayako Konishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.